PXD067725
PXD067725 is an original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Comprehensive Phosphoproteomic Profiling Reveals Sex-Specific Regulatory Mechanisms in HrasG12V-Driven Hepatocarcinogenesis |
| Description | To identify common and sex-specific phosphorylation dynamics during hepatocarcinogenesis in Hras12V transgenic mice (Ras-Tg). We constructed a phosphoproteomic database using male/female tumor (MT/FT), precancerous (MP/FP), and wild-type liver tissues (MW/FW) from Ras-Tg, validated via parallel reaction monitoring (PRM). Comparative analysis and hierarchical clustering were employed to delineate shared and sex-stratified phosphorylation signatures in hepatocellular carcinoma (HCC) development. PRM-validated phosphoproteomic profiling quantified 5,410 phosphorylation sites across 2,427 proteins. Analysis of common features revealed nuclear-enriched phosphoprotein accumulation in tumors versus precancerous/wild-type tissues (T vs P/W). KEGG pathway analysis identified consistently dysregulated pathways including MAPK signaling, focal adhesion, and protein digestion/absorption. Protein-protein interaction (PPI) network analysis of shared phosphoproteins pinpointed key regulators (Alb, Hspa5, Psn). Sex-specific analyses demonstrated distinct phosphorylation patterns: males exhibited extensive membrane protein phosphorylation alterations, while females showed predominant cytoplasmic modifications. KEGG pathway mapping revealed male-biased dysregulation in Ras signaling, mTOR pathways, and actin cytoskeleton regulation. Functional annotation indicated greater complexity of phosphorylated proteins in males. Notably, kinase/phosphatase activity-related phosphorylation events were more prevalent in males, suggesting enhanced phosphorylation-mediated signaling dynamics. This study establishes the first sexual dimorphism-aware phosphoproteomic resource for Ras-driven hepatocarcinogenesis, systematically characterizing conserved and sex-divergent phosphorylation networks. The findings provide mechanistic insights into gender disparities in HCC progression and potential therapeutic targeting. |
| HostingRepository | iProX |
| AnnounceDate | 2025-08-26 |
| AnnouncementXML | Submission_2025-08-25_23:41:54.976.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Huiling Li |
| SpeciesList | scientific name: Mus musculus; NCBI TaxID: 10090; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | Q Exactive Plus |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
|---|---|---|---|
| 0 | 2025-08-25 23:41:28 | ID requested | |
| ⏵ 1 | 2025-08-25 23:41:55 | announced |
Publication List
| Dataset with its publication pending |
Keyword List
| submitter keyword: myasthenia gravis, proteomics, biomarkers, complement coagulation cascade, Cytoskeleton |
Contact List
| Huiling Li | |
|---|---|
| contact affiliation | Dalian Medical University |
| contact email | lhl@dmu.edu.cn |
| lab head | |
| Huiling Li | |
| contact affiliation | Dalian Medical University |
| contact email | 754037170@qq.com |
| dataset submitter | |
Full Dataset Link List
| iProX dataset URI |




